Allergy & Immunology
Disease State Hub
Featured
05/26/2023
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
05/26/2023
Multidisciplinary Roundtable
Multidisciplinary Roundtable
05/17/2023
In this video, Albert Rizzo, MD, speaks with allergist and immunologist Juanita Mora, MD, pediatrician John Harrington, MD, and pulmonary and critical care physician, David Hill, MD about the role of a...
05/17/2023
05/13/2023
Sublingual allergen immunotherapy has been examined as an alternative treatment option in recent years for individuals with allergic asthma. Is this a treatment option you utilize when managing patients...
05/13/2023
Interactive Features
05/13/2023
Sublingual allergen immunotherapy has been examined as an alternative treatment option in recent years for individuals with allergic asthma. Is this a treatment option you utilize when managing patients...
05/13/2023
04/20/2023
Do you know when it is recommended a patient undergo endoscopic sinus surgery after a diagnosis of nasal polyps? Test your knowledge with our latest pop quiz to find out!
04/20/2023
01/03/2023
The AAAAI recently released new recommendations for treating and preventing anaphylaxis. Do you know which risk factor you should consider when determining whether a patient has biphasic anaphylaxis? Take...
01/03/2023
Clinical Insights
05/26/2023
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
05/26/2023
Multidisciplinary Roundtable
Multidisciplinary Roundtable
05/17/2023
In this video, Albert Rizzo, MD, speaks with allergist and immunologist Juanita Mora, MD, pediatrician John Harrington, MD, and pulmonary and critical care physician, David Hill, MD about the role of a...
05/17/2023
05/01/2023
In this video, Amy S. Paller, MD, discusses the efficacy and safety of dupilumab for patients with erythrodermic atopic dermatitis (AD), what these results mean for patients with severe AD, and how her...
05/01/2023
